JPRN-jRCT2080223362未知3 期
An Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of S-033188 after Administration of a Single Dose to Otherwise Healthy Pediatric Patients Aged 6 Months to < 12 Years with Influenza
适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •Patients confirmed with influenza virus infection and within 48 hours from onset.
- •Age: 6 months old or more 11years old or less
排除标准
- •- Patients with severe symptoms of influenza virus infection requiring inpatient treatment.
- •- Patients with high risk factors.
- •- Patients with concurrent infections requiring antimicrobial therapy.
研究者
相似试验
进行中（未招募）
1 期
This Study Will Evaluate the Safety, Tolerability, Activity of the Drug in the Body and Effectiveness of Baloxavir Marboxil Given as Granules in a Single Dose to Otherwise Healthy Children with InfluenzaInfluenzaEUCTR2021-001026-22-Outside-EU/EEAShionogi & Co., Ltd.
进行中（未招募）
不适用
The Safety and Efficacy of Canakinumab in Patients Aged 4 Years or Older Diagnosed With Cryopyrin-associated Periodic Syndromes (CAPS) in CanadaEUCTR2015-003491-69-Outside-EU/EEAovartis Pharmaceuticals4
已完成
1 期
An Open-label Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Dapagliflozin 70 mg Extended Release Capsules in Healthy VolunteersType 2 Diabetes MellitusACTRN12620001187932ovotech (Australia) Pty Limited10
终止
1 期
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Dapagliflozin Extended Release Capsules in Healthy Volunteers.ACTRN12619001577101yndra Australia Pty Ltd44
已完成
1 期
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Rosuvastatin Extended Release CapsulesdyslipidemiaACTRN12621000101886yndra Therapeutics, Inc. (Lyndra)16